Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes.

Mayr C, Bund D, Schlee M, Moosmann A, Kofler DM, Hallek M, Wendtner CM.

Blood. 2005 Feb 15;105(4):1566-73. Epub 2004 Oct 7.

2.

CD23 is recognized as tumor-associated antigen (TAA) in B-CLL by CD8+ autologous T lymphocytes.

Bund D, Mayr C, Kofler DM, Hallek M, Wendtner CM.

Exp Hematol. 2007 Jun;35(6):920-30.

PMID:
17533046
3.

MDM2 is recognized as a tumor-associated antigen in chronic lymphocytic leukemia by CD8+ autologous T lymphocytes.

Mayr C, Bund D, Schlee M, Bamberger M, Kofler DM, Hallek M, Wendtner CM.

Exp Hematol. 2006 Jan;34(1):44-53.

PMID:
16413390
4.
5.

Expression of RHAMM/CD168 and other tumor-associated antigens in patients with B-cell chronic lymphocytic leukemia.

Giannopoulos K, Li L, Bojarska-Junak A, Rolinski J, Dmoszynska A, Hus I, Greiner J, Renner C, Döhner H, Schmitt M.

Int J Oncol. 2006 Jul;29(1):95-103.

PMID:
16773189
6.

Peptide vaccination elicits leukemia-associated antigen-specific cytotoxic CD8+ T-cell responses in patients with chronic lymphocytic leukemia.

Giannopoulos K, Dmoszynska A, Kowal M, Rolinski J, Gostick E, Price DA, Greiner J, Rojewski M, Stilgenbauer S, Döhner H, Schmitt M.

Leukemia. 2010 Apr;24(4):798-805. doi: 10.1038/leu.2010.29. Epub 2010 Mar 11.

PMID:
20220777
7.

Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.

Mikaelsson E, Danesh-Manesh AH, Lüppert A, Jeddi-Tehrani M, Rezvany MR, Sharifian RA, Safaie R, Roohi A, Osterborg A, Shokri F, Mellstedt H, Rabbani H.

Blood. 2005 Jun 15;105(12):4828-35. Epub 2005 Mar 1.

8.

Disruption of T cell suppression in chronic lymphocytic leukemia by CD200 blockade.

Pallasch CP, Ulbrich S, Brinker R, Hallek M, Uger RA, Wendtner CM.

Leuk Res. 2009 Mar;33(3):460-4. doi: 10.1016/j.leukres.2008.08.021. Epub 2008 Oct 5.

PMID:
18838168
9.

Recognition of PSA-derived peptide antigens by T cells from prostate cancer patients without any prior stimulation.

Chakraborty NG, Stevens RL, Mehrotra S, Laska E, Taxel P, Sporn JR, Schauer P, Albertsen PC.

Cancer Immunol Immunother. 2003 Aug;52(8):497-505. Epub 2003 Jun 3.

PMID:
12783216
10.

Transduction of CLL cells by CD40 ligand enhances an antigen-specific immune recognition by autologous T cells.

Mayr C, Kofler DM, Büning H, Bund D, Hallek M, Wendtner CM.

Blood. 2005 Nov 1;106(9):3223-6. Epub 2005 Jul 12.

12.

HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase.

Olson BM, Frye TP, Johnson LE, Fong L, Knutson KL, Disis ML, McNeel DG.

Cancer Immunol Immunother. 2010 Jun;59(6):943-53. doi: 10.1007/s00262-010-0820-6. Epub 2010 Feb 6.

13.

Silencing of ROR1 and FMOD with siRNA results in apoptosis of CLL cells.

Choudhury A, Derkow K, Daneshmanesh AH, Mikaelsson E, Kiaii S, Kokhaei P, Osterborg A, Mellstedt H.

Br J Haematol. 2010 Nov;151(4):327-35. doi: 10.1111/j.1365-2141.2010.08362.x. Epub 2010 Aug 31.

PMID:
20813009
14.
15.

Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes.

Takahashi S, Rousseau RF, Yotnda P, Mei Z, Dotti G, Rill D, Hurwitz R, Marini F, Andreeff M, Brenner MK.

Hum Gene Ther. 2001 Apr 10;12(6):659-70.

PMID:
11426465
16.

An in vitro-transcribed-mRNA polyepitope construct encoding 32 distinct HLA class I-restricted epitopes from CMV, EBV, and Influenza for use as a functional control in human immune monitoring studies.

Nielsen JS, Wick DA, Tran E, Nelson BH, Webb JR.

J Immunol Methods. 2010 Aug 31;360(1-2):149-56. doi: 10.1016/j.jim.2010.07.003. Epub 2010 Jul 15.

PMID:
20637775
17.

Detection and quantification of blood-derived CD8+ T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens.

Herr W, Schneider J, Lohse AW, Meyer zum Büschenfelde KH, Wölfel T.

J Immunol Methods. 1996 May 27;191(2):131-42.

PMID:
8666832
18.

Autoreactive, cytotoxic T lymphocytes specific for peptides derived from normal B-cell differentiation antigens in healthy individuals and patients with B-cell malignancies.

Grube M, Rezvani K, Wiestner A, Fujiwara H, Sconocchia G, Melenhorst JJ, Hensel N, Marti GE, Kwak LW, Wilson W, Barrett JA.

Clin Cancer Res. 2004 Feb 1;10(3):1047-56.

19.

Human tumor-derived heat shock protein 96 mediates in vitro activation and in vivo expansion of melanoma- and colon carcinoma-specific T cells.

Rivoltini L, Castelli C, Carrabba M, Mazzaferro V, Pilla L, Huber V, Coppa J, Gallino G, Scheibenbogen C, Squarcina P, Cova A, Camerini R, Lewis JJ, Srivastava PK, Parmiani G.

J Immunol. 2003 Oct 1;171(7):3467-74.

20.

Study of fibromodulin gene expression in B-cell chronic lymphocytic leukemia.

Hassan DA, Samy RM, Abd-Elrahim OT, Salib CS.

J Egypt Natl Canc Inst. 2011 Mar;23(1):11-5. doi: 10.1016/j.jnci.2011.07.002. Epub 2011 Sep 8.

Supplemental Content

Support Center